SLDB
Solid Biosciences Inc.
+0.10 (+1.20%)8.83USD438K成交股數946M市值–本益比(近四季)116.9股價營收比–營收年增(近四季)2026-11-02下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 0 |
| 近 180 天 淨額 | 0 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 | 07-07 | SMITH IAN F | Director | M 選擇權執行 | 3.4K | – | – | 138K | SEC |
| 2026-04-02 | 04-02 | SMITH IAN F | Director | M 選擇權執行 | 3.4K | – | – | 135K | SEC |
| 2026-02-18 | 02-18 | Hanrahan Jessie | Chief Regulatory Officer | S 公開市場賣出(10b5-1) | 4.1K | 5.82 | 24K | 74.3K | SEC |
| 2026-02-18 | 02-18 | Ganot Ilan | Director | S 公開市場賣出(10b5-1) | 2.7K | 5.82 | 15K | 27.5K | SEC |
| 2026-02-18 | 02-18 | Tan Kevin | CFO & Treasurer | S 公開市場賣出(10b5-1) | 5.4K | 5.82 | 31K | 99.4K | SEC |
| 2026-02-18 | 02-18 | Herzich Paul | Chief Technology Officer | S 公開市場賣出(10b5-1) | 3.6K | 5.82 | 21K | 72.6K | SEC |
| 2026-02-18 | 02-18 | Brooks Gabriel | Chief Medical Officer | S 公開市場賣出(10b5-1) | 0 | 5.82 | 0 | 89.5K | SEC |
| 2026-02-18 | 02-18 | Howton David T | Chief Operating Officer | S 公開市場賣出(10b5-1) | 7.5K | 5.82 | 43K | 105K | SEC |
| 2026-02-18 | 02-18 | Cumbo Alexander | President and CEO | S 公開市場賣出(10b5-1) | 16.6K | 5.82 | 97K | 235K | SEC |
| 2026-02-13 | 02-18 | Cumbo Alexander | President and CEO | M 選擇權執行 | 30.0K | – | – | 252K | SEC |
| 2026-02-13 | 02-18 | Howton David T | Chief Operating Officer | M 選擇權執行 | 14.7K | – | – | 113K | SEC |
| 2026-02-13 | 02-18 | Hanrahan Jessie | Chief Regulatory Officer | M 選擇權執行 | 8.1K | – | – | 78.5K | SEC |
| 2026-02-13 | 02-18 | Ganot Ilan | Director | M 選擇權執行 | 4.9K | – | – | 30.1K | SEC |
| 2026-02-13 | 02-18 | Tan Kevin | CFO & Treasurer | M 選擇權執行 | 10.6K | – | – | 105K | SEC |
| 2026-02-13 | 02-18 | Brooks Gabriel | Chief Medical Officer | M 選擇權執行 | 10.9K | – | – | 95.0K | SEC |
| 2026-02-13 | 02-18 | Herzich Paul | Chief Technology Officer | M 選擇權執行 | 7.2K | – | – | 76.3K | SEC |
| 2026-02-04 | 02-06 | Herzich Paul | Chief Technology Officer | S 公開市場賣出(10b5-1) | 10.9K | 6.44 | 70K | 69.1K | SEC |
| 2026-02-04 | 02-06 | Howton David T | Chief Operating Officer | S 公開市場賣出(10b5-1) | 18.9K | 6.44 | 122K | 97.9K | SEC |
| 2026-02-04 | 02-06 | Ganot Ilan | Director | S 公開市場賣出(10b5-1) | 7.2K | 6.44 | 46K | 25.3K | SEC |
| 2026-02-04 | 02-06 | Tan Kevin | CFO & Treasurer | S 公開市場賣出(10b5-1) | 14.8K | 6.44 | 95K | 94.2K | SEC |
| 2026-02-04 | 02-06 | Hanrahan Jessie | Chief Regulatory Officer | S 公開市場賣出(10b5-1) | 12.3K | 6.44 | 80K | 70.3K | SEC |
| 2026-02-04 | 02-06 | Cumbo Alexander | President and CEO | S 公開市場賣出(10b5-1) | 48.9K | 6.44 | 315K | 222K | SEC |
| 2026-02-04 | 02-06 | Brooks Gabriel | Chief Medical Officer | S 公開市場賣出(10b5-1) | 12.6K | 6.44 | 81K | 84.1K | SEC |
| 2026-02-02 | 02-02 | Howton David T | Chief Operating Officer | S 公開市場賣出(10b5-1) | 37.8K | 6.44 | 243K | 117K | SEC |
| 2026-02-02 | 02-02 | Herzich Paul | Chief Technology Officer | S 公開市場賣出(10b5-1) | 26.3K | 6.44 | 169K | 80.0K | SEC |
| 2026-02-02 | 02-02 | Tan Kevin | CFO & Treasurer | S 公開市場賣出(10b5-1) | 26.8K | 6.44 | 173K | 109K | SEC |
| 2026-02-02 | 02-02 | Hanrahan Jessie | Chief Regulatory Officer | S 公開市場賣出(10b5-1) | 26.5K | 6.44 | 171K | 82.7K | SEC |
| 2026-02-02 | 02-02 | Cumbo Alexander | President and CEO | S 公開市場賣出(10b5-1) | 80.3K | 6.44 | 517K | 271K | SEC |
| 2026-02-02 | 02-02 | Brooks Gabriel | Chief Medical Officer | S 公開市場賣出(10b5-1) | 28.3K | 6.44 | 182K | 96.7K | SEC |
| 2026-01-31 | 02-02 | Ganot Ilan | Director | M 選擇權執行 | 15.0K | – | – | 32.5K | SEC |
| 2026-01-31 | 02-02 | Howton David T | Chief Operating Officer | M 選擇權執行 | 42.3K | – | – | 154K | SEC |
| 2026-01-31 | 02-02 | Herzich Paul | Chief Technology Officer | M 選擇權執行 | 24.7K | – | – | 106K | SEC |
| 2026-01-31 | 02-02 | Tan Kevin | CFO & Treasurer | M 選擇權執行 | 33.1K | – | – | 136K | SEC |
| 2026-01-31 | 02-02 | Brooks Gabriel | Chief Medical Officer | M 選擇權執行 | 28.2K | – | – | 125K | SEC |
| 2026-01-31 | 02-02 | Cumbo Alexander | President and CEO | M 選擇權執行 | 100K | – | – | 351K | SEC |
| 2026-01-31 | 02-02 | Hanrahan Jessie | Chief Regulatory Officer | M 選擇權執行 | 27.6K | – | – | 109K | SEC |
| 2026-01-29 | 02-02 | Brooks Gabriel | Chief Medical Officer | M 選擇權執行 | 58.8K | – | – | 96.8K | SEC |
| 2026-01-29 | 02-02 | Howton David T | Chief Operating Officer | M 選擇權執行 | 79.3K | – | – | 112K | SEC |
| 2026-01-29 | 02-02 | Herzich Paul | Chief Technology Officer | M 選擇權執行 | 54.9K | – | – | 81.5K | SEC |
| 2026-01-29 | 02-02 | Hanrahan Jessie | Chief Regulatory Officer | M 選擇權執行 | 54.9K | – | – | 81.6K | SEC |
| 2026-01-29 | 02-02 | Tan Kevin | CFO & Treasurer | M 選擇權執行 | 56.6K | – | – | 103K | SEC |
| 2026-01-29 | 02-02 | Cumbo Alexander | President and CEO | M 選擇權執行 | 169K | – | – | 251K | SEC |
| 2026-01-28 | 01-30 | Ganot Ilan | Director | S 公開市場賣出(10b5-1) | 191 | 6.59 | 1K | 17.5K | SEC |
| 2026-01-27 | 01-30 | Ganot Ilan | Director | M 選擇權執行 | 3.9K | – | – | 99.3K | SEC |
| 2026-01-27 | 01-30 | Ganot Ilan | Director | M 選擇權執行 | 389 | – | – | 17.7K | SEC |
| 2026-01-13 | 01-13 | Tan Kevin | CFO & Treasurer | S 公開市場賣出(10b5-1) | 5.7K | 5.27 | 30K | 46.1K | SEC |
| 2026-01-09 | 01-13 | Tan Kevin | CFO & Treasurer | M 選擇權執行 | 11.3K | – | – | 51.8K | SEC |
| 2026-01-06 | 01-07 | SMITH IAN F | Director | M 選擇權執行 | 4.6K | – | – | 131K | SEC |
| 2026-01-05 | 01-06 | Ganot Ilan | Director | S 公開市場賣出 | 1.1K | 5.43 | 6K | 17.3K | SEC |
| 2026-01-03 | 01-06 | Ganot Ilan | Director | M 選擇權執行 | 3.0K | – | – | 18.3K | SEC |
| 2025-12-03 | 12-04 | Howton David T | Chief Operating Officer | S 公開市場賣出(10b5-1) | 4.9K | 5.11 | 25K | 32.9K | SEC |
| 2025-12-03 | 12-04 | Cumbo Alexander | President and CEO | S 公開市場賣出(10b5-1) | 10.8K | 5.11 | 55K | 81.4K | SEC |
| 2025-12-03 | 12-04 | Hanrahan Jessie | Chief Regulatory Officer | S 公開市場賣出(10b5-1) | 4.5K | 5.11 | 23K | 26.7K | SEC |
| 2025-12-03 | 12-04 | Herzich Paul | Chief Technology Officer | S 公開市場賣出(10b5-1) | 2.7K | 5.11 | 14K | 26.6K | SEC |
| 2025-12-02 | 12-04 | Herzich Paul | Chief Technology Officer | M 選擇權執行 | 7.2K | – | – | 29.3K | SEC |
| 2025-12-02 | 12-04 | Hanrahan Jessie | Chief Regulatory Officer | M 選擇權執行 | 11.9K | – | – | 31.1K | SEC |
| 2025-12-02 | 12-04 | Howton David T | Chief Operating Officer | M 選擇權執行 | 13.1K | – | – | 37.8K | SEC |
| 2025-12-02 | 12-04 | Cumbo Alexander | President and CEO | M 選擇權執行 | 28.6K | – | – | 92.2K | SEC |
| 2025-11-10 | 11-13 | Ganot Ilan | Director | S 公開市場賣出 | 3.3K | 4.12 | 14K | 95.4K | SEC |
| 2025-10-20 | 10-21 | Brooks Gabriel | Chief Medical Officer | S 公開市場賣出 | 2.9K | 5.96 | 17K | 33.8K | SEC |
| 2025-10-18 | 10-21 | Brooks Gabriel | Chief Medical Officer | M 選擇權執行 | 9.8K | – | – | 36.7K | SEC |
| 2025-10-06 | 10-07 | SMITH IAN F | Director | M 選擇權執行 | 4.6K | – | – | 127K | SEC |
| 2025-07-06 | 07-08 | SMITH IAN F | Director | M 選擇權執行 | 4.6K | – | – | 122K | SEC |
| 2025-04-06 | 04-08 | SMITH IAN F | Director | M 選擇權執行 | 4.6K | – | – | 118K | SEC |
| 2025-03-11 | 03-13 | Kahn Clare | Director | P 公開市場買進 | 1.9K | 5.34 | 10K | 3.0K | SEC |
| 2025-02-19 | 02-21 | Bain Capital Life Sciences Partners, LP | TenPercentOwner | P 公開市場買進 | 1.0M | 4.03 | 4.0M | 5.0M | SEC |
| 2025-02-19 | 02-21 | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Director,TenPercentOwner | P 公開市場買進 | 5.0M | 4.03 | 20.2M | 11.8M | SEC |
| 2025-02-19 | 02-21 | PERCEPTIVE ADVISORS LLC | Director,TenPercentOwner | P 公開市場買進 | 5.0M | 4.03 | 20.2M | 11.8M | SEC |
| 2025-02-19 | 02-21 | EDELMAN JOSEPH | Director,TenPercentOwner | P 公開市場買進 | 5.0M | 4.03 | 20.2M | 11.8M | SEC |
| 2025-02-19 | 02-21 | BCLS II Equity Opportunities GP, LLC | TenPercentOwner | P 公開市場買進 | 1.0M | 4.03 | 4.0M | 5.0M | SEC |
| 2025-02-19 | 02-21 | BCLS II Investco (GP), LLC | TenPercentOwner | P 公開市場買進 | 1.0M | 4.03 | 4.0M | 5.0M | SEC |
| 2025-02-19 | 02-21 | BCLS II Investco, LP | TenPercentOwner | P 公開市場買進 | 1.0M | 4.03 | 4.0M | 5.0M | SEC |
| 2025-02-19 | 02-21 | BCLS II Equity Opportunities, LP | TenPercentOwner | P 公開市場買進 | 1.0M | 4.03 | 4.0M | 5.0M | SEC |
| 2025-02-19 | 02-21 | Bain Capital Life Sciences Investors II, LLC | TenPercentOwner | P 公開市場買進 | 1.0M | 4.03 | 4.0M | 5.0M | SEC |
| 2025-02-19 | 02-21 | Bain Capital Life Sciences Fund II, L.P. | TenPercentOwner | P 公開市場買進 | 1.0M | 4.03 | 4.0M | 5.0M | SEC |
| 2025-02-19 | 02-21 | BCLS SB Investco, LP | TenPercentOwner | P 公開市場買進 | 1.0M | 4.03 | 4.0M | 5.0M | SEC |
| 2025-02-19 | 02-21 | Bain Capital Life Sciences Investors, LLC | TenPercentOwner | P 公開市場買進 | 1.0M | 4.03 | 4.0M | 5.0M | SEC |
| 2025-02-19 | 02-21 | Perceptive Xontogeny Venture Fund, LP | Director,TenPercentOwner | P 公開市場買進 | 5.0M | 4.03 | 20.2M | 11.8M | SEC |
| 2025-02-19 | 02-21 | BCIP Life Sciences Associates, LP | TenPercentOwner | P 公開市場買進 | 1.0M | 4.03 | 4.0M | 5.0M | SEC |
| 2025-02-18 | 02-19 | Atchinson Robert | TenPercentOwner | P 公開市場買進 | 253K | 7.56 | 1.9M | 4.2M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 12.0M | 120M | +2.7M (+29%) | 加碼 |
| PERCEPTIVE ADVISORS LLC | 11.9M | 119M | 不變 | 持平 |
| Bain Capital Life Sciences Investors, LLC | 9.8M | 98.0M | 不變 | 持平 |
| Siren, L.L.C. | 7.7M | 76.8M | 不變 | 持平 |
| BlackRock, Inc. | 6.9M | 69.3M | +2.0M (+40%) | 加碼 |
| FMR LLC | 6.9M | 68.7M | +3.3M (+91%) | 加碼 |
| ARMISTICE CAPITAL, LLC | 4.3M | 42.7M | +1.1M (+34%) | 加碼 |
| STATE STREET CORP | 4.2M | 41.7M | +3.0M (+271%) | 加碼 |
| Jupiter Topco LLC | 4.0M | 40.4M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.0M | 40.1M | +1.3M (+50%) | 加碼 |
| RTW INVESTMENTS, LP | 3.9M | 38.9M | 新進 | 新進 |
| Deep Track Capital, LP | 3.6M | 35.6M | 不變 | 持平 |
| FRANKLIN RESOURCES INC | 3.4M | 34.4M | +1.2M (+57%) | 加碼 |
| 城堡 CITADEL ADVISORS LLC | 2.8M | 28.1M | +218K (+8%) | 加碼 |
| Alyeska Investment Group, L.P. | 2.3M | 22.8M | +359 (+0%) | 加碼 |
| AMERIPRISE FINANCIAL INC | 2.2M | 22.2M | −213K (-9%) | 減碼 |
| Vestal Point Capital, LP | 2.2M | 21.6M | −2.8M (-57%) | 減碼 |
| Redmile Group, LLC | 1.9M | 19.5M | −63.2K (-3%) | 減碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9M | 19.4M | +645K (+50%) | 加碼 |
| GOLDMAN SACHS GROUP INC | 1.6M | 16.0M | +667K (+71%) | 加碼 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.5M | 15.0M | −250K (-14%) | 減碼 |
| DIMENSIONAL FUND ADVISORS LP | 1.3M | 12.6M | +310K (+32%) | 加碼 |
| BLAIR WILLIAM & CO/IL | 756K | 7.6M | +105K (+16%) | 加碼 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 749K | 7.5M | +410K (+121%) | 加碼 |
| Woodline Partners LP | 674K | 6.7M | +179K (+36%) | 加碼 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 156 +12 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 41 / 29 / 56 / 37 |
| 機構合計持股 · 佔流通股 | 115M · 100.0% |
| 合計季末市值 | 1.1B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 16.4M |
|---|---|
| 與上期比 | -1.4% |
| 佔流通股數 | 15.28% |
| 日均成交量 | 866K |
| 回補天數 | 18.9 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 16.4M | -1.4% | 15.28% | 866K | 18.9 |
| 2026-08-14 | 16.6M | -2.4% | 15.50% | 848K | 19.6 |
| 2026-07-31 | 17.0M | -3.6% | 15.89% | 1.1M | 16.2 |
| 2026-07-15 | 17.7M | -3.3% | 16.48% | 1.6M | 11.2 |
| 2026-06-30 | 18.3M | +57.3% | 17.04% | 4.0M | 4.6 |
| 2026-06-15 | 11.6M | +20.9% | 10.83% | 1.3M | 8.9 |
| 2026-05-29 | 9.6M | +5.5% | 8.95% | 1.0M | 9.4 |
| 2026-05-15 | 9.1M | +3.3% | 8.49% | 1.3M | 6.8 |
| 2026-04-30 | 8.8M | -6.7% | 8.22% | 795K | 11.1 |
| 2026-04-15 | 9.4M | -6.0% | 8.81% | 1.0M | 9.4 |
| 2026-03-31 | 10.0M | +3.0% | 9.37% | 1.3M | 8.0 |
| 2026-03-13 | 9.8M | +2.2% | 9.10% | 2.2M | 4.3 |
| 2026-02-27 | 9.5M | +1.2% | 8.90% | 1.0M | 9.1 |
| 2026-02-13 | 9.4M | +8.8% | 8.79% | 1.3M | 7.0 |
| 2026-01-30 | 8.7M | +0.7% | 8.08% | 913K | 9.5 |
| 2026-01-15 | 8.6M | -14.2% | 8.02% | 1.1M | 7.5 |
| 2025-12-31 | 10.0M | +0.9% | 9.35% | 937K | 10.7 |
| 2025-12-15 | 9.9M | -5.7% | 9.27% | 915K | 10.9 |
| 2025-11-28 | 10.5M | +10.4% | 9.83% | 942K | 11.2 |
| 2025-11-14 | 9.6M | +7.1% | 8.91% | 1.6M | 6.1 |
| 2025-10-31 | 8.9M | -6.8% | 8.32% | 833K | 10.7 |
| 2025-10-15 | 9.6M | -6.0% | 8.92% | 1.2M | 8.3 |
| 2025-09-30 | 10.2M | +2.4% | 9.49% | 1.4M | 7.4 |
| 2025-09-15 | 9.9M | +0.9% | 9.27% | 866K | 11.5 |
| 2025-08-29 | 9.8M | +0.7% | 9.18% | 679K | 14.5 |
| 2025-08-15 | 9.8M | -3.3% | 9.12% | 1.1M | 8.5 |